Report Detail

Pharma & Healthcare Global Asparaginase Market Insights, Forecast to 2025

  • RnM2470868
  • |
  • 30 April, 2019
  • |
  • Global
  • |
  • 110 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Asparaginase Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Asparaginase Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Asparaginase Market Size Growth Rate by Product
      • 1.4.2 Escherichia Coli
      • 1.4.3 Erwinia Chrysanthemi
      • 1.4.4 Pegylated
    • 1.5 Market by End User
      • 1.5.1 Global Asparaginase Market Size Growth Rate by End User
      • 1.5.2 Acute Lymphoblastic Leukemia
      • 1.5.3 Acute Myeloid Leukemia
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Asparaginase Market Size
      • 2.1.1 Global Asparaginase Revenue 2014-2025
      • 2.1.2 Global Asparaginase Sales 2014-2025
    • 2.2 Asparaginase Growth Rate by Regions
      • 2.2.1 Global Asparaginase Sales by Regions
      • 2.2.2 Global Asparaginase Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Asparaginase Sales by Manufacturers
      • 3.1.1 Asparaginase Sales by Manufacturers
      • 3.1.2 Asparaginase Sales Market Share by Manufacturers
      • 3.1.3 Global Asparaginase Market Concentration Ratio (CR5 and HHI)
    • 3.2 Asparaginase Revenue by Manufacturers
      • 3.2.1 Asparaginase Revenue by Manufacturers (2014-2019)
      • 3.2.2 Asparaginase Revenue Share by Manufacturers (2014-2019)
    • 3.3 Asparaginase Price by Manufacturers
    • 3.4 Asparaginase Manufacturing Base Distribution, Product Types
      • 3.4.1 Asparaginase Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Asparaginase Product Type
      • 3.4.3 Date of International Manufacturers Enter into Asparaginase Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Asparaginase Sales by Product
    • 4.2 Global Asparaginase Revenue by Product
    • 4.3 Asparaginase Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Asparaginase Breakdown Data by End User

    6 North America

    • 6.1 North America Asparaginase by Countries
      • 6.1.1 North America Asparaginase Sales by Countries
      • 6.1.2 North America Asparaginase Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Asparaginase by Product
    • 6.3 North America Asparaginase by End User

    7 Europe

    • 7.1 Europe Asparaginase by Countries
      • 7.1.1 Europe Asparaginase Sales by Countries
      • 7.1.2 Europe Asparaginase Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Asparaginase by Product
    • 7.3 Europe Asparaginase by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Asparaginase by Countries
      • 8.1.1 Asia Pacific Asparaginase Sales by Countries
      • 8.1.2 Asia Pacific Asparaginase Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Asparaginase by Product
    • 8.3 Asia Pacific Asparaginase by End User

    9 Central & South America

    • 9.1 Central & South America Asparaginase by Countries
      • 9.1.1 Central & South America Asparaginase Sales by Countries
      • 9.1.2 Central & South America Asparaginase Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Asparaginase by Product
    • 9.3 Central & South America Asparaginase by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Asparaginase by Countries
      • 10.1.1 Middle East and Africa Asparaginase Sales by Countries
      • 10.1.2 Middle East and Africa Asparaginase Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Asparaginase by Product
    • 10.3 Middle East and Africa Asparaginase by End User

    11 Company Profiles

    • 11.1 Jazz Pharmaceuticals
      • 11.1.1 Jazz Pharmaceuticals Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Jazz Pharmaceuticals Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Jazz Pharmaceuticals Asparaginase Products Offered
      • 11.1.5 Jazz Pharmaceuticals Recent Development
    • 11.2 Shire
      • 11.2.1 Shire Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Shire Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Shire Asparaginase Products Offered
      • 11.2.5 Shire Recent Development
    • 11.3 Medac GmbH
      • 11.3.1 Medac GmbH Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medac GmbH Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medac GmbH Asparaginase Products Offered
      • 11.3.5 Medac GmbH Recent Development
    • 11.4 Kyowa Hakko Kirin
      • 11.4.1 Kyowa Hakko Kirin Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Kyowa Hakko Kirin Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Kyowa Hakko Kirin Asparaginase Products Offered
      • 11.4.5 Kyowa Hakko Kirin Recent Development
    • 11.5 Qianhong Bio-pharma
      • 11.5.1 Qianhong Bio-pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Qianhong Bio-pharma Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Qianhong Bio-pharma Asparaginase Products Offered
      • 11.5.5 Qianhong Bio-pharma Recent Development
    • 11.6 Taj Pharmaceuticals
      • 11.6.1 Taj Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Taj Pharmaceuticals Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Taj Pharmaceuticals Asparaginase Products Offered
      • 11.6.5 Taj Pharmaceuticals Recent Development
    • 11.7 Mingxing Pharma
      • 11.7.1 Mingxing Pharma Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Mingxing Pharma Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Mingxing Pharma Asparaginase Products Offered
      • 11.7.5 Mingxing Pharma Recent Development
    • 11.8 SL Pharma
      • 11.8.1 SL Pharma Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 SL Pharma Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 SL Pharma Asparaginase Products Offered
      • 11.8.5 SL Pharma Recent Development
    • 11.9 United Biotech
      • 11.9.1 United Biotech Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 United Biotech Asparaginase Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 United Biotech Asparaginase Products Offered
      • 11.9.5 United Biotech Recent Development

    12 Future Forecast

    • 12.1 Asparaginase Market Forecast by Regions
      • 12.1.1 Global Asparaginase Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Asparaginase Revenue Forecast by Regions 2019-2025
    • 12.2 Asparaginase Market Forecast by Product
      • 12.2.1 Global Asparaginase Sales Forecast by Product 2019-2025
      • 12.2.2 Global Asparaginase Revenue Forecast by Product 2019-2025
    • 12.3 Asparaginase Market Forecast by End User
    • 12.4 North America Asparaginase Forecast
    • 12.5 Europe Asparaginase Forecast
    • 12.6 Asia Pacific Asparaginase Forecast
    • 12.7 Central & South America Asparaginase Forecast
    • 12.8 Middle East and Africa Asparaginase Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Asparaginase Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.

      Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
      Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
      Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
      In the last several years, global market of Asparaginase developed stably, with an average growth rate of 1.4%. In 2017, global revenue of Asparaginase is nearly 390 M USD; the actual production is about 590 K Units.
      The global Asparaginase market is valued at 380 million US$ in 2018 and will reach 420 million US$ by the end of 2025, growing at a CAGR of 1.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asparaginase market based on company, product type, end user and key regions.

      This report studies the global market size of Asparaginase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asparaginase in these regions.
      This research report categorizes the global Asparaginase market by top players/brands, region, type and end user. This report also studies the global Asparaginase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Jazz Pharmaceuticals
      Shire
      Medac GmbH
      Kyowa Hakko Kirin
      Qianhong Bio-pharma
      Taj Pharmaceuticals
      Mingxing Pharma
      SL Pharma
      United Biotech

      Market size by Product
      Escherichia Coli
      Erwinia Chrysanthemi
      Pegylated
      Market size by End User
      Acute Lymphoblastic Leukemia
      Acute Myeloid Leukemia
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Asparaginase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Asparaginase market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Asparaginase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Asparaginase submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Asparaginase are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asparaginase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Asparaginase . Industry analysis & Market Report on Asparaginase is a syndicated market report, published as Global Asparaginase Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Asparaginase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,097.46
      4,646.19
      6,194.92
      3,479.81
      5,219.72
      6,959.62
      422,557.20
      633,835.80
      845,114.40
      271,746.15
      407,619.23
      543,492.30
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report